Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Inequalities in lung cancer: a world of EGFR.

Identifieur interne : 001C79 ( Main/Exploration ); précédent : 001C78; suivant : 001C80

Inequalities in lung cancer: a world of EGFR.

Auteurs : Mélodie Carbonnaux [France] ; Pierre-Jean Souquet [France] ; Anne-Pascale Meert [Belgique] ; Arnaud Scherpereel [France] ; Matthew Peters [Australie] ; Sébastien Couraud [France]

Source :

RBID : pubmed:27030679

Abstract

Epidermal growth factor receptor gene (EGFR) mutation status has emerged as a crucial issue in lung cancer management. Availability and cost of tests and tyrosine kinase inhibitors (TKIs) may vary as a function of country development.We conducted a prospective specialist opinion survey to map EGFR test and EGFR-TKI availability and detect associations with the Human Development Index (HDI). A questionnaire was sent to specialists in thoracic oncology in all United Nations Member States.We obtained responses from 74 countries, comprising 78% of the worldwide population. Nonresponding countries had significantly lower HDI rank than responding countries. EGFR mutation analysis was routinely available in 57 countries (70% of the worldwide population). The cost of the test was
DOI: 10.1183/13993003.01157-2015
PubMed: 27030679


Affiliations:


Links toward previous steps (curation, corpus...)

  • to stream PubMed, to step Corpus: 001E73
  • to stream PubMed, to step Curation: 001E49
  • to stream PubMed, to step Checkpoint: 001E49
  • to stream Ncbi, to step Merge: 003348
  • to stream Ncbi, to step Curation: 003348
  • to stream Ncbi, to step Checkpoint: 003348
  • to stream Main, to step Merge: 001C76
  • to stream Main, to step Curation: 001C79

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Inequalities in lung cancer: a world of EGFR.</title>
<author>
<name sortKey="Carbonnaux, Melodie" sort="Carbonnaux, Melodie" uniqKey="Carbonnaux M" first="Mélodie" last="Carbonnaux">Mélodie Carbonnaux</name>
<affiliation wicri:level="3">
<nlm:affiliation>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Souquet, Pierre Jean" sort="Souquet, Pierre Jean" uniqKey="Souquet P" first="Pierre-Jean" last="Souquet">Pierre-Jean Souquet</name>
<affiliation wicri:level="3">
<nlm:affiliation>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Meert, Anne Pascale" sort="Meert, Anne Pascale" uniqKey="Meert A" first="Anne-Pascale" last="Meert">Anne-Pascale Meert</name>
<affiliation wicri:level="4">
<nlm:affiliation>Head of the European Respiratory Society Thoracic Oncology Assembly, Dept of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Head of the European Respiratory Society Thoracic Oncology Assembly, Dept of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
<settlement type="city">Bruxelles</settlement>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author>
<name sortKey="Scherpereel, Arnaud" sort="Scherpereel, Arnaud" uniqKey="Scherpereel A" first="Arnaud" last="Scherpereel">Arnaud Scherpereel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Secretary of the European Respiratory Society Thoracic Oncology Assembly, Pulmonology and Thoracic Oncology Dept, Lille University Hospital, Lille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Secretary of the European Respiratory Society Thoracic Oncology Assembly, Pulmonology and Thoracic Oncology Dept, Lille University Hospital, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Peters, Matthew" sort="Peters, Matthew" uniqKey="Peters M" first="Matthew" last="Peters">Matthew Peters</name>
<affiliation wicri:level="3">
<nlm:affiliation>Representative of the Thoracic Society of Australia and New Zealand, Dept of Thoracic Medicine, Concord Repatriation General Hospital, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Representative of the Thoracic Society of Australia and New Zealand, Dept of Thoracic Medicine, Concord Repatriation General Hospital, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Couraud, Sebastien" sort="Couraud, Sebastien" uniqKey="Couraud S" first="Sébastien" last="Couraud">Sébastien Couraud</name>
<affiliation wicri:level="3">
<nlm:affiliation>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon, France sebastien.couraud@chu-lyon.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
<wicri:regionArea>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27030679</idno>
<idno type="pmid">27030679</idno>
<idno type="doi">10.1183/13993003.01157-2015</idno>
<idno type="wicri:Area/PubMed/Corpus">001E73</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E73</idno>
<idno type="wicri:Area/PubMed/Curation">001E49</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E49</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001E49</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E49</idno>
<idno type="wicri:Area/Ncbi/Merge">003348</idno>
<idno type="wicri:Area/Ncbi/Curation">003348</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003348</idno>
<idno type="wicri:Area/Main/Merge">001C76</idno>
<idno type="wicri:Area/Main/Curation">001C79</idno>
<idno type="wicri:Area/Main/Exploration">001C79</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Inequalities in lung cancer: a world of EGFR.</title>
<author>
<name sortKey="Carbonnaux, Melodie" sort="Carbonnaux, Melodie" uniqKey="Carbonnaux M" first="Mélodie" last="Carbonnaux">Mélodie Carbonnaux</name>
<affiliation wicri:level="3">
<nlm:affiliation>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Souquet, Pierre Jean" sort="Souquet, Pierre Jean" uniqKey="Souquet P" first="Pierre-Jean" last="Souquet">Pierre-Jean Souquet</name>
<affiliation wicri:level="3">
<nlm:affiliation>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Meert, Anne Pascale" sort="Meert, Anne Pascale" uniqKey="Meert A" first="Anne-Pascale" last="Meert">Anne-Pascale Meert</name>
<affiliation wicri:level="4">
<nlm:affiliation>Head of the European Respiratory Society Thoracic Oncology Assembly, Dept of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Head of the European Respiratory Society Thoracic Oncology Assembly, Dept of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
<settlement type="city">Bruxelles</settlement>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author>
<name sortKey="Scherpereel, Arnaud" sort="Scherpereel, Arnaud" uniqKey="Scherpereel A" first="Arnaud" last="Scherpereel">Arnaud Scherpereel</name>
<affiliation wicri:level="3">
<nlm:affiliation>Secretary of the European Respiratory Society Thoracic Oncology Assembly, Pulmonology and Thoracic Oncology Dept, Lille University Hospital, Lille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Secretary of the European Respiratory Society Thoracic Oncology Assembly, Pulmonology and Thoracic Oncology Dept, Lille University Hospital, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Peters, Matthew" sort="Peters, Matthew" uniqKey="Peters M" first="Matthew" last="Peters">Matthew Peters</name>
<affiliation wicri:level="3">
<nlm:affiliation>Representative of the Thoracic Society of Australia and New Zealand, Dept of Thoracic Medicine, Concord Repatriation General Hospital, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Representative of the Thoracic Society of Australia and New Zealand, Dept of Thoracic Medicine, Concord Repatriation General Hospital, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Couraud, Sebastien" sort="Couraud, Sebastien" uniqKey="Couraud S" first="Sébastien" last="Couraud">Sébastien Couraud</name>
<affiliation wicri:level="3">
<nlm:affiliation>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon, France sebastien.couraud@chu-lyon.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
<wicri:regionArea>Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The European respiratory journal</title>
<idno type="eISSN">1399-3003</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Epidermal growth factor receptor gene (EGFR) mutation status has emerged as a crucial issue in lung cancer management. Availability and cost of tests and tyrosine kinase inhibitors (TKIs) may vary as a function of country development.We conducted a prospective specialist opinion survey to map EGFR test and EGFR-TKI availability and detect associations with the Human Development Index (HDI). A questionnaire was sent to specialists in thoracic oncology in all United Nations Member States.We obtained responses from 74 countries, comprising 78% of the worldwide population. Nonresponding countries had significantly lower HDI rank than responding countries. EGFR mutation analysis was routinely available in 57 countries (70% of the worldwide population). The cost of the test was </div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Belgique</li>
<li>France</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Hauts-de-France</li>
<li>Nord-Pas-de-Calais</li>
<li>Nouvelle-Galles du Sud</li>
<li>Rhône-Alpes</li>
<li>Région de Bruxelles-Capitale</li>
</region>
<settlement>
<li>Bruxelles</li>
<li>Lille</li>
<li>Lyon</li>
<li>Sydney</li>
</settlement>
<orgName>
<li>Université libre de Bruxelles</li>
</orgName>
</list>
<tree>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Carbonnaux, Melodie" sort="Carbonnaux, Melodie" uniqKey="Carbonnaux M" first="Mélodie" last="Carbonnaux">Mélodie Carbonnaux</name>
</region>
<name sortKey="Couraud, Sebastien" sort="Couraud, Sebastien" uniqKey="Couraud S" first="Sébastien" last="Couraud">Sébastien Couraud</name>
<name sortKey="Scherpereel, Arnaud" sort="Scherpereel, Arnaud" uniqKey="Scherpereel A" first="Arnaud" last="Scherpereel">Arnaud Scherpereel</name>
<name sortKey="Souquet, Pierre Jean" sort="Souquet, Pierre Jean" uniqKey="Souquet P" first="Pierre-Jean" last="Souquet">Pierre-Jean Souquet</name>
</country>
<country name="Belgique">
<region name="Région de Bruxelles-Capitale">
<name sortKey="Meert, Anne Pascale" sort="Meert, Anne Pascale" uniqKey="Meert A" first="Anne-Pascale" last="Meert">Anne-Pascale Meert</name>
</region>
</country>
<country name="Australie">
<region name="Nouvelle-Galles du Sud">
<name sortKey="Peters, Matthew" sort="Peters, Matthew" uniqKey="Peters M" first="Matthew" last="Peters">Matthew Peters</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C79 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C79 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27030679
   |texte=   Inequalities in lung cancer: a world of EGFR.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27030679" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024